(Press-News.org) Reston, VA—The field of nuclear medicine is in the spotlight this season on the TV documentary Jobs of Tomorrow. The series, hosted by Kristin Marand, explores how technology and innovation drive the changing job market and impact the workforce.
Six episodes of this season of Jobs of Tomorrow highlight the many facets of nuclear medicine and the Society for Nuclear Medicine and Molecular Imaging (SNMMI) members currently working in the profession.
Nuclear medicine is a multidisciplinary field that encompasses physicians, chemists, physicists, pharmacists, and technologists—all of whom play vital roles in the field and are at the forefront of medical innovation, working toward breakthroughs to improve the care of patients with cancer, Alzheimer’s, cardiovascular disorders and other diseases. A type of nuclear medicine known as “theranostics” is particularly promising, combining diagnostics and therapies to detect and treat specific cancers.
“The field of nuclear medicine is exploding as we combine both diagnosis and therapy, the so-called theranostic field,” said Dr. Helen Nadel, the current president of SNMMI, in episode 9. “That means that we can use a small amount of radioactive drug to diagnose a problem, and then we can apply a different radioactive drug to potentially treat it.”
Episodes for this season of Jobs of Tomorrow will be released throughout June and July on Amazon, Roku, Tubi, and other popular streaming platforms. SNMMI’s first featured episode, “From Diagnosis to Therapy: the Evolution of Theranostics,” premiered on May 31 and is now available to stream on snmmi.org/nmcareers.
###
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
END
Nuclear medicine highlighted in documentary series
2024-06-06
ELSE PRESS RELEASES FROM THIS DATE:
Serine racemase expression in the brain during aging in male and female rats
2024-06-05
“The findings of the present study reveal that aging is linked to a decline in serine racemase protein levels across various brain regions [...]”
BUFFALO, NY- June 5, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 10, entitled, “Serine racemase expression profile in the prefrontal cortex and hippocampal subregions during aging in male and female rats.”
Aging is associated with a decrease in N-methyl-D-aspartate (NMDA) receptor ...
Virginia Tech researcher helps reach nutrition security goals
2024-06-05
Food is many things.
It nourishes our bodies, delights our senses, and gives us something to gather around. Food is also a powerful cultural symbol, reflecting traditions, values, and histories of communities around the world.
But for a researcher in the College of Agriculture and Life Sciences, food is also medicine.
Bailey Houghtaling Ph.D. ’19, a registered dietician, is working to promote overall wellness among low-income individuals experiencing food insecurity, aiming to prevent or treat diet-related diseases.
“Access to enough nutritious food is essential for individual well-being,” ...
William T. Grant Foundation announces funding for UT, Cherokee Health Systems for research-practice partnership
2024-06-05
Trustees of the William T. Grant Foundation, the Spencer Foundation, the Doris Duke Foundation and the Bezos Family Foundation have approved funding for the winners of the 2024 Institutional Challenge Grant competition. The University of Tennessee, Knoxville, and Cherokee Health Systems will receive $650,000 to grow their unique research-practice partnership — and to learn how to implement community-engaged scholarship that results in ongoing positive outcomes.
UT has a long history of working with CHS, a federally qualified ...
Democratizing plant research: A new cost-effective solution for advanced phenotyping
2024-06-05
Phenotyping, which involves assessing observable plant characteristics, is crucial for understanding plant development and response to environmental stresses. Traditional methods are often cumbersome, costly, and destructive, limiting research scope and scale. A new system of affordable, mobile, and high-throughput phenotyping tools is making the technology accessible to a wider range of users.
The "all-in-one" solution, developed by a team at the Boyce Thompson Institute (BTI), includes low-cost hardware designs, data processing pipelines, and a user-friendly data analysis ...
Multiple randomized trials prove more stroke patients can benefit from thrombectomy
2024-06-05
FOR IMMEDIATE RELEASE: June 5, 2024
CONTACT: Faith James
fjames@vancomm.com or 202-248-5450
Multiple Randomized Trials Prove More Stroke Patients Can Benefit from Thrombectomy
Society of NeuroInterventional Surgery issues update to standards and guidelines following research in favor of minimally invasive procedure for deadly type of stroke
FAIRFAX, Va. — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion (BAO), a deadly type ...
Researchers led by UMass Amherst solve 2,000-year-old mystery of the shipworm
2024-06-05
June 5, 2024
Researchers Led by UMass Amherst Solve 2,000-Year-Old Mystery of the Shipworm
Secret of the world’s most destructive and intriguing mollusk has implications for everything from climate change to human health
AMHERST, Mass. – They bedeviled ancient Greek navies, helped shipwreck Christopher Columbus, aided in the sinking of the Spanish Armada and caused the wharves in San Francisco Bay to collapse into the sea, but until now, scientists have been unable to pinpoint exactly ...
Immunotherapy before surgery very successful in treating colorectal cancer
2024-06-05
A short course of immunotherapy was found to be highly effective in a subset of patients with colon cancer. The treatment, which consisted of two cycles of immunotherapy prior to surgery, was effective in almost all patients. In two third of patients, there were no longer any live tumor cells at the time of surgery. The patients’ immune system had cleaned up the cancer cells. These groundbreaking discoveries were made as part of the NICHE-2 trial at the Netherlands Cancer Institute and have been published in the New England Journal of Medicine.
Patients with colon cancer with ...
Encouraging Phase 1 data for glioblastoma treatment reported by UAB researchers at ASCO
2024-06-05
BIRMINGHAM, Ala. – Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham demonstrated that 92 percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months with concomitant temozolomide chemotherapy. The median follow-up was 11.7 months.
This survival data along with radiographic improvements are indicative of positive treatment effects, which highlights the potential of IN8bio’s genetically modified, chemotherapy-resistant gamma-delta T cells ...
YALE NEWS: Early life experiences linked to racial disparities in cognition
2024-06-05
New Haven, Conn. — Negative early life experiences, such as attending segregated schools, contribute significantly to cognitive decline and cognition disparities between older Black and white Americans, according to a new study led by researchers at the Yale School of Public Health.
The study, published in JAMA Internal Medicine, is the first to look at the impact of school segregation upon later life cognition using a large representative sample of the U.S. population, said lead author Xi Chen, associate professor of public ...
Nationally known pediatric infectious disease researcher named vice chancellor for research at the University of Tennessee Health Science Center
2024-06-05
After an extensive national search, Jessica Snowden, MD, MS, FAAP, MHPTT, a nationally recognized pediatric infectious disease specialist and researcher, has been named the new vice chancellor for Research at the University of Tennessee Health Science Center, effective September 1. She will also serve as a professor in the College of Medicine in the Department of Pediatrics.
Currently the vice dean for Research and chief of Pediatric Infectious Diseases at the University of Arkansas for Medical Sciences (UAMS), Dr. Snowden is known as a dedicated mentor and a leader in integrating clinical, research, and academic efforts to advance the understanding ...